Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...

Infusion therapies are typically used for patients with advanced Parkinson’s disease, who experience significant motor fluctuations despite conventional oral treatment. These therapies offer several ...

PORTLAND, IL, UNITED STATES, February 6, 2025 /EINPresswire / -- Alarming rise in prevalence of disorders such as cancer and diabetes, rise in healthcare expenditures, rise in government & private ...

MRI-Compatible IV Infusion Pump Systems MarketThe global market for MRI-compatible IV infusion pump systems is set for significant expansion, driven by advancements in medical imaging and increasing ...

The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...

Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...

Drip in a hospital emergency room. Modern medical equipment on a background. 4K. Close up of nurse or doctor preparing and adjusting infusion or chemotherapy drip for the male patient in hospital or ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...